These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 573103)

  • 41. [Bioavailability of theophylline after oral administration of a retard preparation of theophylline-ethylenediamine and the influence of 15-day ingestion on elimination kinetics after i.v. injection (author's transl)].
    Wiessmann KJ
    Arzneimittelforschung; 1980; 30(2):329-32. PubMed ID: 7378114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pharmacokinetic study of an antibacterial agent: clofoctol after intravenous administration in the rabbit (author's transl)].
    Koskas JP; Leverge R; Devissaguet JP
    J Pharm Belg; 1982; 37(1):72-7. PubMed ID: 7077515
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effect of 15 antineoplastic drugs on colon carcinoma growing in vitro: a screening assay for cytotoxicity (author's transl)].
    Gouget N; Jeannin JF; Olsson O; Martin F
    Bull Cancer; 1980; 67(2):155-60. PubMed ID: 7448437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of lactone, carboxylate and total 9-nitrocamptothecin with different doses and administration routes in rats.
    Chen J; Ping Q; Guo J; Chu X; Song M
    Biopharm Drug Dispos; 2006 Mar; 27(2):53-9. PubMed ID: 16299828
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Antitumor effect of compounds synthesized in the Division of Synthetic Chemistry. (III) (author's transl)].
    Miyahara M; Kamiya S; Nakadate M; Sueyoshi S; Tanno M; Miyahara M; Maekawa A; Odashima S
    Eisei Shikenjo Hokoku; 1979; (97):107-9. PubMed ID: 543939
    [No Abstract]   [Full Text] [Related]  

  • 46. [Antineoplastic spectrum of mitoxantrone in rat ascitic hepatoma].
    Satoh H
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):26-30. PubMed ID: 7184361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pharmacokinetics after oral and intravenous administration of tetracycline compounds (author's transl)].
    Dimmling T; Vanderbeke O
    Med Klin; 1975 Feb; 70(7):279-85. PubMed ID: 804588
    [No Abstract]   [Full Text] [Related]  

  • 48. [Pharmacokinetic studies after oral and parenteral application of dipotassium chlorazepate (author's transl)].
    Staak M; Moosmayer A; Besserer K; Speidel K; Kleinschmidt A
    Arzneimittelforschung; 1982; 32(3):272-5. PubMed ID: 6123331
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Description of the pharmacokinetic behaviour of Etozolin and its main metabolite (author's transl)].
    Gladigau V; Vollmer KO
    Arzneimittelforschung; 1977; 27(9a):1786-99. PubMed ID: 578768
    [No Abstract]   [Full Text] [Related]  

  • 51. Stability, absorption, excretion, and distribution of nafiverine.
    Naito S; Yamamoto T
    J Pharm Sci; 1975 Feb; 64(2):253-8. PubMed ID: 1127581
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Phase study (author's transl)].
    Yokoyama M
    Nihon Gan Chiryo Gakkai Shi; 1979 Feb; 14(1):51-2. PubMed ID: 438590
    [No Abstract]   [Full Text] [Related]  

  • 53. [Absorption, distribution, excretion and metabolism of carbazilquinone; a new anti-tumor agent, in mice (author's transl)].
    Shindo H; Nambu K; Nakajima E; Kawai K
    Yakugaku Zasshi; 1974 Nov; 94(11):1393-403. PubMed ID: 4478167
    [No Abstract]   [Full Text] [Related]  

  • 54. Naproxen oral absorption characteristics.
    Runkel RA; Kraft KS; Boost G; Sevelius H; Forchielli E; Hill R; Magoun R; Szakacs JB; Segre E
    Chem Pharm Bull (Tokyo); 1972 Jul; 20(7):1457-66. PubMed ID: 4640447
    [No Abstract]   [Full Text] [Related]  

  • 55. [Studies on the fate of 5-fluoro-1,3-bis(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FD-1), a new antitumor agent. I. Absorption, distribution, excretion and metabolism of FD-1 administered orally to rats (author's transl)].
    Kawaguchi Y; Nakamura Y; Sato T; Takeda S; Marunaka T; Fujii S
    Yakugaku Zasshi; 1978 Apr; 98(4):525-36. PubMed ID: 660420
    [No Abstract]   [Full Text] [Related]  

  • 56. Organophosphorus compounds as schistosomicides.
    Werbel LM; Thompson PE
    J Med Chem; 1967 Jan; 10(1):32-6. PubMed ID: 4961978
    [No Abstract]   [Full Text] [Related]  

  • 57. [The effect of administration routes on the absorption, metabolism and excretion of sulpyrin in rats (author's transl)].
    Nogami H; Hanano M; Awazu S; Imaoka K
    Yakugaku Zasshi; 1973 Dec; 93(12):1603-10. PubMed ID: 4361311
    [No Abstract]   [Full Text] [Related]  

  • 58. [A dye uptake method using cultured human cancer cells and its application to a sensitivity test for anti-cancer drug (author's transl)].
    Isomura J; Yoshimatsu K; Ikeda T; Takimoto G; Morimoto T
    Yakugaku Zasshi; 1981 Mar; 101(3):227-31. PubMed ID: 7299633
    [No Abstract]   [Full Text] [Related]  

  • 59. [Pharmacokinetic studies on aristolochic acid in rats by an ultraviolet spectrophotometric method].
    Xiang ZX; He XQ; Zhou GF; Li CH
    Yao Xue Xue Bao; 1984 Mar; 19(3):224-7. PubMed ID: 6496096
    [No Abstract]   [Full Text] [Related]  

  • 60. Metabolic pathway of cytostatic dibromohexitols.
    Institóris L; Horváth IP; Pethes G; Eckhardt S
    Cancer Chemother Rep; 1967 Sep; 51(5):261-70. PubMed ID: 6062296
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.